Viewing Study NCT00002180



Ignite Creation Date: 2024-05-05 @ 9:35 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00002180
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: A Study of PMPA in HIV-Infected Patients
Sponsor: Gilead Sciences
Organization: NIH AIDS Clinical Trials Information Service

Study Overview

Official Title: A Phase III Randomized Double-Blind Placebo-Controlled Study of the Safety Tolerance and Pharmacokinetics and Antiviral Activity of 9-R-2-PhosphonomethoxyPropyl Adenine PMPA in HIV-Infected Patients
Status: COMPLETED
Status Verified Date: 1999-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to see if it is safe and effective to give PMPA to HIV-infected patients This study also examines how the body handles PMPA
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
Secondary ID Type Domain Link
GS-96-701 None None None